within the speedily evolving industry of oncology study, precise and economical mutation screening is vital for producing specific therapies. The KRAS providers Platform performs a pivotal purpose In this particular landscape by providing complete options for KRAS mutation profiling and Examination. KRAS mutations, located in around 95% of RAS-conn